|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
$0.00 0.00 (0.00%) as of 4:30 Mon 5/6
|
|
Download |
|
|
|
|
Exchange: |
Nasdaq Small Cap |
Security
Type: |
N/A |
Shares
Out: |
239,210,000 |
Market
Cap: |
478.42(K) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.000001 - $1.3 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Amyris is a biotechnology company. Co. creates, manufactures and commercializes consumer products and ingredients. Co.'s ingredients and consumer products are powered by its fermentation-based Lab-to-Market technology platform. Co. has produced a renewable farnesene brand, Biofene®, a long-chain, branched hydrocarbon molecule that Co. manufactures through fermentation using engineered microbes. Co. has formulated its fermentation-based ingredients such as Squalane, Hemisqualane, and Steviol Glycoside Rebaudioside M into its consumer brands. Co.'s consumer brands include: Biossance® clean beauty skincare, Pipette® clean baby skincare, and Purecane sweetener.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
17,155 |
Total Buy Value |
$0 |
$0 |
$0 |
$69,135 |
Total People Bought |
0 |
0 |
0 |
1 |
Total Buy Transactions |
0 |
0 |
0 |
1 |
Total Shares Sold |
0 |
0 |
0 |
4,354,080 |
Total Sell Value |
$0 |
$0 |
$0 |
$15,807,372 |
Total People Sold |
0 |
0 |
0 |
5 |
Total Sell Transactions |
0 |
0 |
0 |
12 |
End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Doerr L John |
Director |
|
2017-06-06 |
4 |
OE |
$15.00 |
$13,037,595 |
I/I |
869,173 |
869,173 |
|
- |
|
Weaver Karen |
Principal Accounting Officer |
|
2017-06-01 |
4 |
D |
$0.25 |
$42 |
D/D |
(167) |
136,754 |
|
- |
|
Melo John |
President and CEO |
|
2017-06-01 |
4 |
D |
$0.25 |
$13,469 |
D/D |
(53,238) |
926,697 |
|
- |
|
Cherry Joel |
President of R&D |
|
2017-06-01 |
4 |
D |
$0.25 |
$3,486 |
D/D |
(13,779) |
929,492 |
|
- |
|
Eykerman Philip |
Director |
|
2017-05-22 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
30,000 |
|
- |
|
Yang Patrick Y |
Director |
|
2017-05-19 |
4 |
B |
$0.29 |
$58,380 |
D/D |
200,000 |
353,000 |
2.39 |
- |
|
Yang Patrick Y |
Director |
|
2017-05-18 |
4 |
B |
$0.29 |
$29,050 |
D/D |
100,000 |
153,000 |
2.39 |
- |
|
Valiasek Kathleen |
Chief Financial Officer |
|
2017-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
70,000 |
251,955 |
|
- |
|
Cherry Joel |
President of R&D |
|
2017-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
371,000 |
943,271 |
|
- |
|
Weaver Karen |
Principal Accounting Officer |
|
2017-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
69,000 |
136,921 |
|
- |
|
Doerr L John |
Director |
|
2017-05-11 |
4 |
D |
$1.00 |
$13,037,586 |
I/I |
(13,037,586) |
0 |
|
- |
|
Cherry Joel |
President of R&D |
|
2017-05-01 |
4 |
D |
$0.52 |
$13,148 |
D/D |
(25,053) |
572,271 |
|
- |
|
Weaver Karen |
Principal Accounting Officer |
|
2017-05-01 |
4 |
D |
$0.52 |
$2,813 |
D/D |
(5,360) |
67,921 |
|
- |
|
Melo John |
President and CEO |
|
2017-05-01 |
4 |
D |
$0.52 |
$27,939 |
D/D |
(53,238) |
979,935 |
|
- |
|
Total Raffinage Chimie |
Director |
|
2017-04-20 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
64,178,185 |
|
- |
|
Total Gas & Power Usa, Sas |
Director by Deputization |
|
2017-04-20 |
4 |
D |
$0.00 |
$0 |
D/D |
(64,178,185) |
0 |
|
- |
|
Temasek Holdings Ltd |
10% Owner |
|
2017-04-20 |
4 |
S |
$0.51 |
$160,839 |
D/D |
(313,649) |
49,538,771 |
|
- |
|
Temasek Holdings Ltd |
10% Owner |
|
2017-04-19 |
4 |
S |
$0.59 |
$198,439 |
D/D |
(338,864) |
49,852,420 |
|
- |
|
Temasek Holdings Ltd |
10% Owner |
|
2017-04-18 |
4 |
S |
$0.61 |
$425,001 |
D/D |
(699,705) |
50,191,284 |
|
- |
|
Temasek Holdings Ltd |
10% Owner |
|
2017-04-17 |
4 |
S |
$0.68 |
$640,218 |
D/D |
(937,225) |
50,890,989 |
|
- |
|
Melo John |
President and CEO |
|
2017-04-01 |
4 |
D |
$0.52 |
$19,466 |
D/D |
(37,580) |
1,033,173 |
|
- |
|
Cherry Joel |
President of R&D |
|
2017-04-01 |
4 |
D |
$0.52 |
$5,826 |
D/D |
(11,248) |
597,324 |
|
- |
|
Weaver Karen |
Principal Accounting Officer |
|
2017-04-01 |
4 |
D |
$0.52 |
$680 |
D/D |
(1,313) |
73,281 |
|
- |
|
Temasek Holdings Ltd |
10% Owner |
|
2017-03-30 |
4 |
S |
$0.51 |
$94,482 |
D/D |
(184,535) |
51,828,214 |
|
- |
|
Temasek Holdings Ltd |
10% Owner |
|
2017-03-29 |
4 |
S |
$0.52 |
$155,643 |
D/D |
(300,470) |
52,012,749 |
|
- |
|
638 Records found
|
|
Page 10 of 26 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|